+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Bone Growth Stimulators Market By Product, By Application, By Distribution Channel, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5026390
  • Report
  • April 2020
  • Region: Middle East, Africa
  • 91 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • Johnson and Johnson
  • Medtronic PLC
  • Orthofix Medical, Inc.
  • Smith & Nephew PLC
  • MORE
The Latin America, Middle East and Africa Bone Growth Stimulators Market is expected to witness market growth of 8% CAGR during the forecast period (2020-2026).

Bone growth stimulation is used to facilitate bone healing in fractures or fusions that are difficult to heal by applying electrical or ultrasonic current to the fracture/fusion site. An electrical osteogenesis stimulator is a tool that provides electrical stimulation to improve bone repair. Electrical stimulation may be performed either from the outside of the body (non-invasive) or from the inside of the body (invasive).

A non-invasive electrical stimulator is characterized by an external power source that is connected to a coil or electrodes mounted on the skin or on casting or brace over a fracture or fusion site. The ultrasonic osteogenesis stimulator is a non-invasive system that emits low pressure, pulsed ultrasound. The ultrasound signal is applied to the surface of the skin at the fracture site using an ultrasound conductive coupling gel to facilitate fracture healing.

External bone stimulation systems are worn out of the skin and do not need surgical implantation or extraction. In comparison to an internal (implanted) bone growth stimulator, an external bone growth stimulator can also be used for use by the patient several weeks or months after fusion surgery if the bone is not healed as desired.

The market for bone growth stimulators is mainly driven by factors such as the occurrence of bone and joint disorders, the demand for non-invasive and minimally invasive surgery across the globe, among others. Globally, osteoarthritis is the most common articular condition in people 65 years of age and older. Moreover, growing numbers of injuries and injury cases are considered to be one of the high-impact factors likely to fuel demand for bone growth stimulator products.

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. Based on Distribution Channel, the market is segmented into Hospitals & Clinics, Home Care and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Medtronic PLC, Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Terumo Corporation (Terumo BCT, Inc.), Colfax Corporation (DJO Global, Inc.), Orthofix Medical, Inc., Arthrex, Inc., Bioventus LLC

Scope of the Study

Market Segmentation:

By Product
  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins and
  • Platelet-Rich Plasma
By Application
  • Spinal Fusion Surgeries
  • Delayed Union & Nonunion Bone Fractures
  • Oral & Maxillofacial Surgeries and
  • Others
By Distribution Channel
  • Hospitals & Clinics
  • Home Care and
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled:
  • Johnson and Johnson
  • Medtronic PLC
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew PLC
  • Terumo Corporation (Terumo BCT, Inc.)
  • Colfax Corporation (DJO Global, Inc.)
  • Orthofix Medical, Inc.
  • Arthrex, Inc.
  • Bioventus LLC
Unique Offerings from the Publisher:
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • Johnson and Johnson
  • Medtronic PLC
  • Orthofix Medical, Inc.
  • Smith & Nephew PLC
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Bone Growth Stimulators Market, by Product
1.4.2 LAMEA Bone Growth Stimulators Market, by Application
1.4.3 LAMEA Bone Growth Stimulators Market, by Distribution Channel
1.4.4 LAMEA Bone Growth Stimulators Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Bone Growth Stimulators Market by Product
3.1 LAMEA Bone Growth Stimulation Devices Market by Country
3.2 LAMEA Bone Morphogenetic Proteins Market by Country
3.3 LAMEA Platelet-Rich Plasma Market by Country

Chapter 4. LAMEA Bone Growth Stimulators Market by Application
4.1 LAMEA Spinal Fusion Surgeries Market by Country
4.2 LAMEA Delayed Union & Nonunion Bone Fractures Market by Country
4.3 LAMEA Oral & Maxillofacial Surgeries Market by Country
4.4 LAMEA Other Application Market by Country

Chapter 5. LAMEA Bone Growth Stimulators Market by Distribution Channel
5.1 LAMEA Hospitals & Clinics Market by Country
5.2 LAMEA Home Care Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Bone Growth Stimulators Market by Country
6.1 Brazil Bone Growth Stimulators Market
6.1.1 Brazil Bone Growth Stimulators Market by Product
6.1.2 Brazil Bone Growth Stimulators Market by Application
6.1.3 Brazil Bone Growth Stimulators Market by Distribution Channel
6.2 Argentina Bone Growth Stimulators Market
6.2.1 Argentina Bone Growth Stimulators Market by Product
6.2.2 Argentina Bone Growth Stimulators Market by Application
6.2.3 Argentina Bone Growth Stimulators Market by Distribution Channel
6.3 UAE Bone Growth Stimulators Market
6.3.1 UAE Bone Growth Stimulators Market by Product
6.3.2 UAE Bone Growth Stimulators Market by Application
6.3.3 UAE Bone Growth Stimulators Market by Distribution Channel
6.4 Saudi Arabia Bone Growth Stimulators Market
6.4.1 Saudi Arabia Bone Growth Stimulators Market by Product
6.4.2 Saudi Arabia Bone Growth Stimulators Market by Application
6.4.3 Saudi Arabia Bone Growth Stimulators Market by Distribution Channel
6.5 South Africa Bone Growth Stimulators Market
6.5.1 South Africa Bone Growth Stimulators Market by Product
6.5.2 South Africa Bone Growth Stimulators Market by Application
6.5.3 South Africa Bone Growth Stimulators Market by Distribution Channel
6.6 Nigeria Bone Growth Stimulators Market
6.6.1 Nigeria Bone Growth Stimulators Market by Product
6.6.2 Nigeria Bone Growth Stimulators Market by Application
6.6.3 Nigeria Bone Growth Stimulators Market by Distribution Channel
6.7 Rest of LAMEA Bone Growth Stimulators Market
6.7.1 Rest of LAMEA Bone Growth Stimulators Market by Product
6.7.2 Rest of LAMEA Bone Growth Stimulators Market by Application
6.7.3 Rest of LAMEA Bone Growth Stimulators Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Approvals:
7.3 Zimmer Biomet Holdings, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Stryker Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Smith & Nephew PLC
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.6 Terumo Corporation (Terumo BCT, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Colfax Corporation (DJO Global, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Orthofix Medical, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Approvals:
7.9 Arthrex, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.1 Bioventus LLC
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
  • Johnson and Johnson
  • Medtronic PLC
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew PLC
  • Terumo Corporation (Terumo BCT, Inc.)
  • Colfax Corporation (DJO Global, Inc.)
  • Orthofix Medical, Inc.
  • Arthrex, Inc.
  • Bioventus LLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll